BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

Free Newsletters
My Subscriptions

News by Subject
News by Disease
News by Date
Search News
Post Your News

Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Pharm Country
  Bio NC
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™


Company Profiles

Research Store

Research Events
Post an Event
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    

Prenatek, Inc. Announces New CEO

7/14/2008 8:47:36 AM

DUBLIN, CA--(MARKET WIRE)--Jul 14, 2008 -- Prenatek™, Inc., an early stage developer of innovative products for detection and management of fetal well-being, today announced that Dennis J. Meister has been named president and chief executive officer, effective immediately. Meister, who brings more than 25 years of experience in leading product and market development of medical devices serving Women's Health, will also serve on the Prenatek Board of Directors.

"Dennis has a proven track record in creating and establishing product leadership positions in the Ob/Gyn markets," said Adnan Shennib, founder and chairman of Prenatek. "He brings deep knowledge and experience in perinatal medicine, and has the managerial skill set to lead Prenatek through successful product and market launches. We are excited to have Dennis join our team."

Prenatek is developing the world's first disposable "smart patch" for continuous fetal monitoring. This new approach employs passive miniature sensors embedded in a low cost, extended wear patch, for safe and comfortable monitoring and detection of abnormal fetal heart rate patterns indicative of fetal distress. The smart patch will offer long-term fetal monitoring at a fraction of the current cost, with unparalleled convenience, and with sufficient diagnostic capabilities for the obstetrician to detect early signs of fetal distress. For others with normal pregnancy, this type of monitoring provides much needed assurance for the mother.

"Prenatek has a unique product vision and technologies with the potential to improve the obstetrical standard-of-care while concurrently reducing the overall cost-of-care in at-risk pregnancies," said Meister. "We also have the opportunity to provide families with needed reassurance during normal pregnancies. Our near term focus is on securing the investment needed to realize our exciting product vision."

Meister began his career in Ob/Gyn clinical applications with ADR Ultrasound, the pioneer and market leader that established real-time ultrasound as the Ob/Gyn standard-of-care. ADR later merged into ATL, now part of Philips Medical. Meister subsequently joined Acuson Corporation and led the company's entrance into the emerging High-Risk Ob/Gyn segment, quickly achieving the sustained market leadership position. While with Acuson, he held a variety of senior management positions in Product Marketing, Clinical Marketing, Product Development Engineering, International Marketing, Strategic Planning, Business Development, Product Portfolio Management, and ultimately General Manager of the flagship Acuson Sequoia(TM) Ultrasound Imaging Platform. Upon the acquisition of Acuson by Siemens Corporation in 2000, Meister held various senior management positions and he also led the formation of a new organization focused on establishing Siemens as the global leader in Ob/Gyn clinical applications. Meister holds a degree in Biomedical Engineering from Marquette University and completed graduate studies in Finance and Marketing at Seattle University.

About Prenatek -- Innovations for new fetal monitoring standard

Prenatek(TM), Inc. was founded in 2004 by Adnan Shennib, a serial entrepreneur with a proven track record in creating and leading medical device innovations. The company is developing the world's first disposable "smart patch" for continuous fetal monitoring. The new approach is designed to offer long-term fetal monitoring at a fraction of the current cost with sufficient diagnostic capabilities for clinicians to detect early signs of fetal distress. Additional information can be found by visiting

Prenatek is a trademark of Prenatek, Inc.


Media Contact: Amy Cook AMC Public Relations LLC 925.552.7893

Source: Prenatek

Read at